Implantica AG (FRA:8IM1)

Germany flag Germany · Delayed Price · Currency is EUR
4.795
-0.030 (-0.62%)
At close: Dec 4, 2025
63.37%
Market Cap 1.35B
Revenue (ttm) 1.99M
Net Income (ttm) -19.74M
Shares Out n/a
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 413
Open 4.795
Previous Close 4.825
Day's Range 4.795 - 4.795
52-Week Range 2.250 - 7.540
Beta n/a
RSI 44.67
Earnings Date Feb 13, 2026

About Implantica AG

Implantica AG engages in the research and distribution of medical implants in Switzerland. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitu... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2015
Employees 50
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8IM1
Full Company Profile

Financial Performance

In 2024, Implantica AG's revenue was 1.94 million, an increase of 37.50% compared to the previous year's 1.41 million. Losses were -23.33 million, -1.73% less than in 2023.

Financial Statements

News

There is no news available yet.